Target Price | $22.14 |
Price | $12.24 |
Potential |
80.91%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Stoke Therapeutics Inc 2025 .
The average Stoke Therapeutics Inc target price is $22.14.
This is
80.91%
register free of charge
$35.00
185.95%
register free of charge
$14.00
14.38%
register free of charge
|
|
A rating was issued by 9 analysts: 8 Analysts recommend Stoke Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Stoke Therapeutics Inc stock has an average upside potential 2025 of
80.91%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 8.78 | 14.87 |
29.25% | 69.35% | |
EBITDA Margin | -1,253.30% | -795.29% |
54.27% | 36.54% | |
Net Margin | -1,417.97% | -765.62% |
29.38% | 46.01% |
9 Analysts have issued a sales forecast Stoke Therapeutics Inc 2024 . The average Stoke Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Stoke Therapeutics Inc EBITDA forecast 2024. The average Stoke Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Stoke Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Stoke Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.38 | -2.18 |
8.46% | 8.40% | |
P/E | negative | |
EV/Sales | 24.76 |
5 Analysts have issued a Stoke Therapeutics Inc forecast for earnings per share. The average Stoke Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Stoke Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Stoke Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.